Diphenoxylate en es it fr

Categoria

Diphenoxylate Nombres de marca, Diphenoxylate Analogos

Diphenoxylate Marca los nombres de mezcla

  • Lomotil (Atropine Sulfate + Diphenoxylate Hcl)
  • Diphenoxylate Formula quimica

    C30H32N2O2

    Diphenoxylate RX enlace

    http://www.rxlist.com/cgi/generic3/diphenoxylate.htm

    Diphenoxylate FDA hoja

    Diphenoxylate MSDS (hoja de seguridad de materiales)

    Diphenoxylate MSDS

    Diphenoxylate Sintesis de referencia

    Janssen, EE.UU. Pat. 2,898,340 (1959)

    Diphenoxylate Peso molecular

    452.587 g/mol

    Diphenoxylate Punto de fusion

    221 oC

    Diphenoxylate H2O Solubilidad

    0,8 mg / ml

    Diphenoxylate Estado

    Solid

    Diphenoxylate LogP

    7.385

    Diphenoxylate Formas de dosificacion

    Solución oral; Tablet

    Diphenoxylate Indicacion

    Para la terapia como adyuvante en el tratamiento de la diarrea

    Diphenoxylate Farmacologia

    Difenoxilato, un antidiarreico, es eficaz como tratamiento adyuvante en el tratamiento de la diarrea. Difenoxilato es rápida y extensamente metabolizado en el hombre por hidrólisis del éster del ácido diphenoxylic (difenoxine), que es biológicamente activo y el principal metabolito en la sangre.

    Diphenoxylate Absorcion

    90%

    Diphenoxylate Toxicidad

    Coma, piel seca y las membranas mucosas, dilatación de las pupilas de los ojos, la temperatura corporal extremadamente alta, enrojecimiento facial, movimiento involuntario del globo ocular, menor que el tono muscular normal, pupilas, taquicardia, agitación, lentitud, suprime la respiración

    Diphenoxylate Informacion de Pacientes

    INFORM THE PATIENT (PARENT OR GUARDIAN) NOT TO EXCEED THE RECOMMENDED DOSAGE AND TO KEEP DIPHEN-OXYLATE HCL AND ATROPINE SULFATE OUT OF THE REACH OF CHILDREN AND IN A CHILD-RESISTANT CONTAINER, INFORM THE PATIENT OF THE CONSEQUENCES OF OVERDOSAGE, INCLUDING SEVERE RESPIRATORY DEPRESSION AND COMA, POSSIBLY LEADING TO PERMANENT BRAIN DAMAGE OR DEATH.

    Diphenoxylate HCl and atropine sulfate may produce drowsiness or dizziness. The patient should be cautioned regarding activities requiring mental alertness, such as driving or operati ng dangerous machinery. Potentiation of the action of alcohol, barbiturates and tranquilizers with concomitant use of diphenoxylate HCl and atropine sulfate should be explained to the patient. The physician should also provide the patient with other information in this labeling, as appropriate.

    Diphenoxylate Organismos afectados

    Humanos y otros mamíferos